• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物对数剂量分档对根特大学医院药学配制效率的影响。

The impact of logarithmic dose banding of anticancer drugs on pharmacy compounding efficiency at Ghent University Hospital.

作者信息

Claus Barbara, Pourcq Kaat De, Clottens Nele, Kruse Vibeke, Gemmel Paul, Vandenbroucke Johan

机构信息

Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.

Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

出版信息

Eur J Hosp Pharm. 2018 Nov;25(6):334-336. doi: 10.1136/ejhpharm-2016-001093. Epub 2017 Mar 4.

DOI:10.1136/ejhpharm-2016-001093
PMID:31157053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319401/
Abstract

BACKGROUND

Dose banding (DB) (dose rounding with predetermined variation with prescription) enables in-advance preparation of high-turnover anticancer drugs with potential benefit for pharmacy compounding work flow.

OBJECTIVES

To analyse the impact of potential situations on the efficiency of DB in the pharmacy (safe and maximum storage), calculate preparation lead times and the potential full-time equivalent (FTE) benefit.

METHODS

Candidate intravenous anticancer drugs were selected for logarithmic DB according to prescribing frequency, infusion volume and stability (usage data 2015 of the tertiary Ghent University Hospital, Belgium). With a selected DB set already stored, a 2-week time study (April/November 2015) provided lead times (between prescription and transfer) for just-in-time and DB preparations. A 'maximal' storage (using all drugs with a relative incidence of ≥2% recurrent monthly prescription) and a 'safe' storage scenario (lowest monthly prescribing pattern) were used to calculate the potential future FTE change.

RESULTS

Mean lead times for DB storage and just-in-time preparation were 17.1 min (95% CI 13.5 to 21.0) and 26.5 min (23.3 to 29.8). For 21 164 yearly preparations with already 5292 in DB (25%), 11 157 and 6 862 could be batch-produced in advance in a maximum storage and safe storage scenario, respectively. The existing FTE in 2015 of 5.41 could then be reduced to 4.91 and 5.27.

CONCLUSION

Further development of DB could contribute to pharmacy compounding efficiency.

摘要

背景

剂量分档(DB)(根据处方进行预定变化的剂量舍入)能够提前准备高周转抗癌药物,对药房配药工作流程具有潜在益处。

目的

分析潜在情况对药房中剂量分档(DB)效率(安全和最大存储)的影响,计算准备前置时间和潜在的全职等效(FTE)效益。

方法

根据比利时根特大学三级医院2015年的用药数据,按照处方频率、输注量和稳定性选择候选静脉用抗癌药物进行对数剂量分档。在已经存储了选定的剂量分档组的情况下,进行了为期2周的时间研究(2015年4月/11月),以提供即时准备和剂量分档准备的前置时间(从处方到调配)。使用“最大”存储(使用所有月复现处方相对发生率≥2%的药物)和“安全”存储方案(最低月处方模式)来计算未来潜在的全职等效(FTE)变化。

结果

剂量分档存储和即时准备的平均前置时间分别为17.1分钟(95%置信区间13.5至21.0)和26.5分钟(23.3至29.8)。对于每年21164次准备,其中已有5292次采用剂量分档(25%),在最大存储和安全存储方案中,分别可以提前批量生产11157次和6862次。2015年现有的全职等效(FTE)为5.41,届时可分别降至4.91和5.27。

结论

剂量分档(DB)的进一步发展有助于提高药房配药效率。

相似文献

1
The impact of logarithmic dose banding of anticancer drugs on pharmacy compounding efficiency at Ghent University Hospital.抗癌药物对数剂量分档对根特大学医院药学配制效率的影响。
Eur J Hosp Pharm. 2018 Nov;25(6):334-336. doi: 10.1136/ejhpharm-2016-001093. Epub 2017 Mar 4.
2
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding.抗肿瘤对数剂量分档实施的探索性分析。
Int J Clin Pharm. 2018 Oct;40(5):1281-1291. doi: 10.1007/s11096-018-0714-9. Epub 2018 Aug 10.
3
Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.通过机器人系统串联制备剂量分段更昔洛韦输液袋的实施和微生物稳定性。
Eur J Hosp Pharm. 2020 Jul;27(4):209-215. doi: 10.1136/ejhpharm-2018-001745. Epub 2018 Nov 26.
4
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs.分析手动和机器人混合配置用于肠外危险药物的生产时间和产能。
Eur J Hosp Pharm. 2024 Jun 21;31(4):352-357. doi: 10.1136/ejhpharm-2022-003576.
5
[Implementation and assessment of anticancer drugs batch preparation circuit in a teaching hospital].[教学医院抗癌药物批量制备流程的实施与评估]
Ann Pharm Fr. 2018 Jul;76(4):306-320. doi: 10.1016/j.pharma.2018.03.001. Epub 2018 Apr 4.
6
Robotized compounding of oncology drugs in a hospital pharmacy.医院药房中肿瘤药物的自动化调配
Int J Pharm Compd. 2014 Sep-Oct;18(5):358-64.
7
Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology.抗肿瘤药物调配机器人在降低肿瘤科医院药剂科手工调配风险中的作用。
J Oncol Pharm Pract. 2023 Sep;29(6):1334-1342. doi: 10.1177/10781552221118846. Epub 2022 Aug 8.
8
Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital.日本一家医院中用于注射用抗癌药物的配药机器人APOTECAchemo的性能评估
J Pharm Health Care Sci. 2017 Apr 24;3:12. doi: 10.1186/s40780-017-0081-z. eCollection 2017.
9
Potential risks of pharmacy compounding.药剂配制的潜在风险。
Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9.
10
Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center.利用肿瘤药物的先进准备:缩短门诊输液中心的周转时间。
J Oncol Pharm Pract. 2021 Sep;27(6):1454-1460. doi: 10.1177/1078155220960222. Epub 2020 Sep 24.

引用本文的文献

1
Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study.临床、经济和组织方面的影响:药师干预对注射用抗肿瘤药物处方的影响:一项前瞻性观察研究。
BMC Health Serv Res. 2020 Feb 12;20(1):113. doi: 10.1186/s12913-020-4963-7.

本文引用的文献

1
Cost avoidance from dose rounding biologic and cytotoxic antineoplastics.生物制剂和细胞毒性抗肿瘤药剂量取整带来的成本节约。
J Oncol Pharm Pract. 2017 Jul;23(5):379-383. doi: 10.1177/1078155216639756. Epub 2016 Mar 21.
2
SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.SFPO和ESOP关于抗癌药物实际稳定性的建议:最新情况
Ann Pharm Fr. 2013 Nov;71(6):376-89. doi: 10.1016/j.pharma.2013.06.002. Epub 2013 Aug 28.
3
Long-term physico-chemical stability of diluted trastuzumab.曲妥珠单抗稀释液的长期物理化学稳定性。
Int J Pharm. 2013 May 1;448(1):101-4. doi: 10.1016/j.ijpharm.2013.02.039. Epub 2013 Mar 4.
4
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.剂量分组作为基于体表面积的化疗药物剂量方案的替代方案。
Br J Cancer. 2012 Sep 25;107(7):1100-6. doi: 10.1038/bjc.2012.357. Epub 2012 Aug 28.
5
Long-term stability of diluted solutions of the monoclonal antibody rituximab.利妥昔单抗单克隆抗体稀释液的长期稳定性。
Int J Pharm. 2012 Oct 15;436(1-2):282-90. doi: 10.1016/j.ijpharm.2012.06.063. Epub 2012 Jul 10.
6
Guidelines for the practical stability studies of anticancer drugs: a European consensus conference.抗癌药物实际稳定性研究指南:欧洲共识会议
Ann Pharm Fr. 2011 Jul;69(4):221-31. doi: 10.1016/j.pharma.2011.07.002. Epub 2011 Aug 3.
7
Dose standardisation of anticancer drugs.抗癌药物的剂量标准化。
Int J Clin Pharm. 2011 Apr;33(2):221-8. doi: 10.1007/s11096-010-9478-6. Epub 2011 Jan 14.
8
Current challenges in European oncology pharmacy practice.欧洲肿瘤药学实践中的当前挑战。
J Oncol Pharm Pract. 2010 Mar;16(1):9-18. doi: 10.1177/1078155209354346. Epub 2009 Dec 16.
9
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.奥沙利铂在聚氯乙烯、聚乙烯和聚丙烯输液袋中 5%葡萄糖注射液中的物理化学稳定性。
Am J Health Syst Pharm. 2009 Nov 1;66(21):1929-33. doi: 10.2146/ajhp090039.
10
Physical and chemical stability of pemetrexed in infusion solutions.培美曲塞在输液溶液中的物理和化学稳定性。
Ann Pharmacother. 2006 Jun;40(6):1082-5. doi: 10.1345/aph.1G715. Epub 2006 May 23.